Resorbable bone materials Archives

Study shows no increased cancer risk with Medtronic’s InFuse

June 7, 2016 By Brad Perriello

A study of nearly 17,000 patients who had spine fusion procedures showed no increased cancer risk with the InFuse bone-growth protein made by Medtronic (NYSE:MDT). The retrospective cohort study, published online last week in the journal Spine, used data from the Washington State Comprehensive Hospital Abstract Reporting System, the Washington State Cancer Registry and death certificates from […]

FDA expands indication for Medtronic’s InFuse bone graft

December 11, 2015 By Brad Perriello

Medtronic (NYSE:MDT) said today that the FDA expanded the indication for its controversial InFuse bone-growth protein, allowing for its use with polyetheretherketone implants in oblique lateral interbody fusion and anterior lumbar interbody fusion surgeries. The new indications cover single-level fusion OLIF51 procedures from the L5 vertebra to S1 with Medtronic’s PEEK Perimeter implant; OLIF25 fusions from L2 to L5 […]

J&J’s DePuy Synthes Trauma debuts Conform Flex biologic implant for extremities repair

October 9, 2015 By Brad Perriello

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes Trauma today debuted its Conform Flex biologic implant for extremities repair in the U.S. Conform Flex is a pre-hydrated demineralized cancellous bone tissue matrix uses DePuy’s Q-Pack technology, an ambient temperature packing technology designed to allow the matrix to ship fully hydrated, the company said. It’s indicated for trauma-related extremity procedures […]

Plaintiff takes Infuse case against Medtronic to the Supreme Court

September 18, 2015 By Brad Perriello

The plaintiff in a product liability lawsuit asked the U.S. Supreme Court to take up the case, involving alleged off-label promotion of Medtronic‘s (NYSE:MDT) controversial Infuse bone-growth protein. Patricia Caplinger wants the high court to review an April decision by the U.S Court of Appeals for the 10th Circuit that her state-law tort claims are preempted by federal law. Caplinger […]